Henri Beaufour
Born
Henri Pierre Albert Marie Beaufour

January 1965 (age 58–59)
NationalityFrench
Alma materGeorgetown University
Board member ofIpsen
ParentAlbert Beaufour
RelativesAnne Beaufour (sister)

Henri Beaufour (born January 6, 1965[1]) is a French businessman and billionaire. He is a descendant of Henri Beaufour, founder of the Beaufour laboratories, forerunner of the French biopharmaceutical company Ipsen.[2]  

Biography

Born in January 1965, in Neuilly-sur-Seine, Henri Beaufour is the son of Albert Beaufour, who died in 2000, and the grandson of Dr. Henri Beaufour, founder of the Ipsen group.[2]

He holds a bachelor's of arts from Georgetown University (Washington, D.C.).

When Albert Beaufour died in 2000, the 76% of the capital held by the family was divided between the three brothers and sisters. One of the daughters, Véronique Beaufour, sold her share, representing 6% of the capital. Anne and her brother Henri Beaufour thus control 57% of the Ipsen group, and both sit on the Board of Directors of Ipsen and Mayroy, the Ipsen controlling holding company. Their share in Ipsen is still 52% in 2020.[3]  

In 2018, his fortune is estimated at Euro 3 billion.[4][5]

References

  1. ↑ https://find-and-update.company-information.service.gov.uk/company/01749071/filing-history?page=5
  2. 1 2 Mariette Finet & Elisabeth Hennebert (2012). From Beaufour to Ipsen. Qualibris edition.
  3. ↑ "Un nouveau président pour Beaufour-Ipsen". Les Echos (in French). 2001-12-05. Retrieved 2022-12-13.
  4. ↑ "Henri Beaufour". Forbes. Retrieved 2022-12-13.
  5. ↑ Challenges (2022-06-06). "Anne Beaufour et Henri Beaufour ainsi que leur famille - Les 500 plus grandes fortunes de France". Challenges (in French). Retrieved 2022-12-13.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.